Survival Outcomes Among Patients With Hepatocellular Carcinoma in a Large Integrated US Health System
Open Access
- 3 September 2024
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 7 (9) , e2435066
Abstract
Hepatocellular carcinoma (HCC) is the most common cause of cancer-related morbidity and mortality globally,1,2 and it is the leading oncologic cause of death among patients with cirrhosis. The incidence of HCC has more than doubled in the US over the past 2 decades, and this trend is expected to continue over the next 20 years.3-5 Although an increasing number of treatment options and improved patient selection6,7 have led to modest improvements in outcomes, HCC remains a difficult-to-treat cancer.8Keywords
This publication has 57 references indexed in Scilit:
- Dynamic risk profiling of HCC recurrence after curative intent liver resectionHepatology, 2022
- Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY StudyHepatology, 2021
- National Experience on Down‐Staging of Hepatocellular Carcinoma Before Liver Transplant: Influence of Tumor Burden, Alpha‐Fetoprotein, and Wait TimeHepatology, 2019
- Alpha‐Fetoprotein Decrease from > 1,000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant OutcomesHepatology, 2018
- Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver DiseasesHepatology, 2018
- Downstaging of hepatocellular cancer before liver transplant: Long‐term outcome compared to tumors within Milan criteriaHepatology, 2015
- World Medical Association Declaration of HelsinkiJAMA, 2013
- Benefit of Initial Resection of Hepatocellular Carcinoma Followed by Transplantation in Case of RecurrenceHepatology, 2011
- Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinomaHepatology, 2010
- Radiofrequency ablation of hepatocellular carcinoma: Long-term results and prognostic factors in 235 Western patients with cirrhosis #Hepatology, 2009